These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8895809)

  • 1. Potential use of iron chelators against oxidative damage.
    Galey JB
    Adv Pharmacol; 1997; 38():167-203. PubMed ID: 8895809
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the design of iron chelators against oxidative damage.
    Galey JB
    Mini Rev Med Chem; 2001 Sep; 1(3):233-42. PubMed ID: 12369970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron chelators can protect against oxidative stress through ferryl heme reduction.
    Reeder BJ; Hider RC; Wilson MT
    Free Radic Biol Med; 2008 Feb; 44(3):264-73. PubMed ID: 18215735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of lipophilic iron chelators as protective agents from oxidative stress.
    Yavin E; Kikkiri R; Gil S; Arad-Yellin R; Yavin E; Shanzer A
    Org Biomol Chem; 2005 Aug; 3(15):2685-7. PubMed ID: 16032345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of U937 cells against oxidative injury by a novel series of iron chelators.
    Galey JB; Destrée O; Dumats J; Pichaud P; Marché J; Génard S; Bracciolli G; Le Capitaine L; Plessix H; Brambilla L; Cantoni O
    Free Radic Biol Med; 1998 Nov; 25(8):881-90. PubMed ID: 9840732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural iron chelators: Protective role in A549 cells of flavonoids-rich extracts of Citrus juices in Fe(3+)-induced oxidative stress.
    Ferlazzo N; Visalli G; Cirmi S; Lombardo GE; Laganà P; Di Pietro A; Navarra M
    Environ Toxicol Pharmacol; 2016 Apr; 43():248-56. PubMed ID: 27037654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative treatment paradigm for thalassemia using iron chelators.
    Szuber N; Buss JL; Soe-Lin S; Felfly H; Trudel M; Ponka P
    Exp Hematol; 2008 Jul; 36(7):773-85. PubMed ID: 18456387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel mitochondrial iron chelator 5-((methylamino)methyl)-8-hydroxyquinoline protects against mitochondrial-induced oxidative damage and neuronal death.
    Mena NP; García-Beltrán O; Lourido F; Urrutia PJ; Mena R; Castro-Castillo V; Cassels BK; Núñez MT
    Biochem Biophys Res Commun; 2015 Aug; 463(4):787-92. PubMed ID: 26051278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
    Bendova P; Mackova E; Haskova P; Vavrova A; Jirkovsky E; Sterba M; Popelova O; Kalinowski DS; Kovarikova P; Vavrova K; Richardson DR; Simunek T
    Chem Res Toxicol; 2010 Jun; 23(6):1105-14. PubMed ID: 20521781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress.
    Shackelford RE; Manuszak RP; Johnson CD; Hellrung DJ; Link CJ; Wang S
    DNA Repair (Amst); 2004 Oct; 3(10):1263-72. PubMed ID: 15336622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of iron metabolism: molecular and cellular criteria for the selection of iron chelators.
    Crichton RR; Ward RJ
    Curr Med Chem; 2003 Jun; 10(12):997-1004. PubMed ID: 12678672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?
    Kaur D; Andersen JK
    Aging Cell; 2002 Oct; 1(1):17-21. PubMed ID: 12882349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia.
    Fibach E; Rachmilewitz EA
    Ann N Y Acad Sci; 2010 Aug; 1202():10-6. PubMed ID: 20712766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
    Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.
    Hašková P; Jansová H; Bureš J; Macháček M; Jirkovská A; Franz KJ; Kovaříková P; Šimůnek T
    Toxicology; 2016 Sep; 371():17-28. PubMed ID: 27744045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of various iron chelators used in clinical practice as protecting agents against catecholamine-induced oxidative injury and cardiotoxicity.
    Hašková P; Koubková L; Vávrová A; Macková E; Hrušková K; Kovaříková P; Vávrová K; Simůnek T
    Toxicology; 2011 Nov; 289(2-3):122-31. PubMed ID: 21864640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin protection against UVA-induced iron damage by multiantioxidants and iron chelating drugs/prodrugs.
    Reelfs O; Eggleston IM; Pourzand C
    Curr Drug Metab; 2010 Mar; 11(3):242-9. PubMed ID: 20406189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New iron chelators in anthracycline-induced cardiotoxicity.
    Kaiserová H; Simunek T; Sterba M; den Hartog GJ; Schröterová L; Popelová O; Gersl V; Kvasnicková E; Bast A
    Cardiovasc Toxicol; 2007; 7(2):145-50. PubMed ID: 17652820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against oxidative damage by iron chelators: effect of lipophilic analogues and prodrugs of N,N'-bis(3,4,5-trimethoxybenzyl)ethylenediamine- N,N'-diacetic acid (OR10141).
    Galey JB; Destrée O; Dumats J; Génard S; Tachon P
    J Med Chem; 2000 Apr; 43(7):1418-21. PubMed ID: 10753479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N,N'-bis-(3,4,5-trimethoxybenzyl) ethylenediamine N,N'-diacetic acid as a new iron chelator with potential medicinal applications against oxidative stress.
    Galey JB; Dumats J; Genard S; Destree O; Pichaud P; Cctroux P; Marrot L; Beck I; Fernandez B; Barre G
    Biochem Pharmacol; 1996 Jan; 51(2):103-15. PubMed ID: 8615878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.